BRS5 - Gut-Brain Axis & Enteric Nervous System
The Gut-Brain Axis & Enteric Nervous System system covers gut barrier integrity, microbial ecology, short-chain fatty acid and polyphenol-derived metabolite signalling, endotoxin containment, and vagal-enteric communication under dietary, immune, and circadian pressure. It links fermentable fibres, plant diversity, barrier-supportive nutrients, fermented foods, and microbiome-active polyphenols to gut-immune containment, microbial metabolite output, and gut-derived neuromodulatory support.
ADHD: Gut–Brain Axis & Enteric Nervous System Biological Implications
Introduction
The gut microbiome's dominant phyla, Firmicutes and Bacteroidetes, and their relative abundance (F/B ratio) are often considered broad indicators of gut ecological balance. Increasing taxonomic diversity can expand capacity to produce beneficial metabolites such as urolithin A, support omega-3 metabolism, and reduce harmful gut-derived metabolites.
Gut health influences production of neurotransmitter precursors including serotonin, GABA, and dopamine. While gut-derived neurotransmitters are unlikely to cross the blood–brain barrier, precursors such as tryptophan and tyrosine do, enabling local synthesis in the brain.
Gut–brain signalling occurs via the vagus nerve, transmitting microbial and neurochemical cues that influence mood and motivation. Vagal stimulation has demonstrated clinical benefits in depression, epilepsy, and inflammation; preclinical work shows gut microbes such as Lactobacillus can alter brain GABA receptor expression through vagal pathways.
The gut barrier is the dynamic interface between microbiome, immune system, and brain. When barrier integrity weakens, bacterial fragments such as lipopolysaccharide (LPS) and dietary antigens enter circulation, sustaining chronic low-grade inflammation and altering neurotransmitter metabolism.
The barrier comprises four interdependent layers: microbiota (fibre and polyphenol loss reduces SCFA protection), mucus (eroded by low plant diversity and ultra-processed foods), epithelium (disrupted by nutrient deficiencies, alcohol, NSAIDs, and chronic stress), and immune interface (influenced by omega-3 and vitamin A context).
When weaknesses converge, LPS can fuel systemic inflammation and impair insulin sensitivity. Metabolic endotoxemia—chronically elevated circulating LPS—is common in Western dietary patterns. Small intestinal bacterial overgrowth (SIBO) can impair absorption of vitamin B12, iron, and tryptophan.
Prebiotics, probiotics, high-fibre diets, and fermented foods (psychobiotics) have been associated with changes in attentional vigilance and mood regulation; galacto-oligosaccharides (GOS) have been linked to reduced anxiety and cortisol. SCFAs such as butyrate support barrier integrity, immune regulation, and neurotransmitter precursor context.
ADHD: Gut–Brain Axis Context
Microbiota categorisation in ADHD remains inconsistent and taxonomy is still evolving. Some studies note reduced Faecalibacterium prausnitzii and Bifidobacterium; others report slightly increased Bifidobacterium in ADHD—functional effects depend on strain-level biology, not genus labels alone.
The gut–brain connection may play a significant role in ADHD aetiology. Barrier weakening correlates with poor cognitive function, fatigue, mood instability, and ADHD symptom severity in some cohorts.
Decreased microbial alpha diversity has been reported in ADHD and may contribute to increased permeability and low-grade systemic inflammation.
Butyrate may reduce neuroinflammation and support mitochondrial brain energy metabolism relevant to cognitive impairment in ADHD.
Propionate may reduce neuroinflammation, protect the blood–brain barrier, and stimulate norepinephrine secretion, with possible relevance to attention and focus.
Lower Bifidobacterium longum abundance in infancy has been associated with increased risk of developing ADHD and Asperger syndrome; early Lactobacillus rhamnosus GG administration showed hypothesis-generating protective signals in a small study—interpreted as an early-life modulation window rather than definitive prevention.
References
- A growing body of evidence suggests that modulating the gut microbiome can positively influence brain health and overall health. The gut is central in producing neurotransmitters, reducing systemic inflammation and enhancing gut-brain axis communication with fibre and fermented foods playing a central role Wastyk et al. 2021
- Increasing the diversity of taxa can increase the possibilities for individuals to produce certain health beneficial metabolites such as Urolithin A, or increase omega 3 metabolism and reduce downstream harmful gut metabolites Schleupner and Carmichael 2022
- Some studies noted reduced levels of beneficial bacteria such as Faecalibacterium prausnitzii and Bifidobacterium in ADHD subjects Wang et al. 2024
- Conversely, other studies found that individuals with ADHD had slightly increased Bifidobacterium Aarts et al. 2017
- The gut-brain connection may also play a significant role in the etiology of ADHD Jiang et al. 2018
- Gut–brain signaling occurs via the vagus nerve, which transmits microbial and neurochemical cues to influence mood and motivation. Vagal stimulation has demonstrated clinical benefits in depression, epilepsy, and inflammation Austelle et al. 2022
- Gut microbes such as Lactobacillus can alter brain GABA receptor expression through vagal pathways Bravo et al. 2011
- A decreased microbial diversity (alpha diversity) has also been reported in ADHD Prehn-Kristensen et al. 2018
- Interventions such as prebiotics, probiotics, high-fibre diets, and fermented foods, collectively referred to as psychobiotics, have been associated with changes in attentional vigilance and mood regulation Schmidt et al. 2015
- Galacto-oligosaccharides (GOS) being linked to reduced anxiety and cortisol Johnstone et al. 2021
- Short-chain fatty acids (SCFAs) like butyrate support intestinal barrier integrity, regulate immune responses, antioxidant activity, and promote the synthesis of key neurotransmitters such as dopamine and serotonin Silva et al. 2020
- Butyrate supports mitochondrial function, enhancing brain energy metabolism, which may help with cognitive impairments seen in ADHD Rose et al. 2018
- Butyrate aids in reducing cholesterol and neuroinflammation Cavaliere et al. 2022
- Increased propionate levels could help reduce neuroinflammation and enhance cognitive function while protecting the blood-brain barrier Grüter et al. 2023
- Propionate can stimulate the secretion of norepinephrine, possibly benefiting ADHD symptoms like attention and focus Hoyles et al. 2018
- A lowered abundance of Bifidobacterium longum in infancy has been associated with increased risk of developing ADHD and Asperger syndrome in childhood Pärtty et al. 2015
Functional Mechanisms
Functional Mechanisms (FMs) are the primary navigational layer of the BRAIN Framework. Each FM represents an integrated biological function supported by one or more Primary Mechanisms (PMs) beneath it.
BRS5(FM1) — Gut Barrier Integrity & Immune Interface
Diet-actionable control point regulating epithelial tight-junction integrity, mucus protection, and immune containment at the gut-brain interface.
Mechanisms:
- BRS5-FM1-PM1 — Gut Barrier / Tight Junction Integrity
- BRS5-FM1-PM2 — LPS / Endotoxin Containment
- BRS5-FM1-PM3 — Keystone Taxa Support
BRS5(FM2) — Microbial Metabolite Signalling Capacity
Functional control point governing production of beneficial microbial metabolites that shape immune, endocrine, and neurobiological signalling.
Mechanisms:
- BRS5-FM2-PM4 — Microbial Ecological Turnover & Competitive Selection
- BRS5-FM2-PM5 — SCFA Production & Signalling
- BRS5-FM2-PM6 — Polyphenol Biotransformation & Mitochondrial-Relevant Metabolite Generation
BRS5(FM3) — Gut-Vagal Neuromodulation & ENS Signalling
Diet-actionable control point regulating vagal and enteric signalling through microbial activity, barrier state, and metabolite/neurochemical cues.
Mechanisms:
- BRS5-FM3-PM7 — Vagal / ENS Signalling Modulation
- BRS5-FM3-PM8 — Neurotransmitter Precursor Biotransformation & Availability
Requirements (Key Constraints)
Key Constraints (KCs) in BRS5 describe shared substrate, precursor, and structural biological pools whose availability constrains the effective operation of multiple primary mechanisms. They act as distributed biological infrastructure supporting multiple downstream mechanisms simultaneously.
- BRS5(KC1) - Fermentable Fibre Availability: Availability of fermentable fibres and resistant starch required to sustain microbial fermentation and SCFA production.
- BRS5(KC2) - Polyphenol & Plant-Diversity Input Availability: Availability of microbiome-active polyphenols and broad plant diversity required to support microbial ecology and biotransformation.
- BRS5(KC3) - Barrier-Supportive Nutrient Sufficiency: Availability of nutrients that support epithelial maintenance, mucosal immunity, and barrier resilience.
Specific Mechanisms
Specific Mechanisms (SMs) are interpretation layers — context-specific readings of stable BRS5 biology grounded in connected PMs, FMs, and KCs. They provide additional biological context for applying the BRAIN Framework. Current SM categories include SM-SNP (genetic variation), SM-Male and SM-Female (sex-specific biology), SM-Lifestage (e.g. childhood, pregnancy, older adulthood), SM-Pattern (e.g. vegan, vegetarian, ketogenic), and SM-Phenotype (e.g. hyperarousal, emotional dysregulation, sensory regulation). Individual SMs may be combined to create richer biological profiles and support future precision-nutrition applications.